Different stability and proteasome-mediated degradation rate of SMN protein isoforms

Denise Locatelli, Mineko Terao, Mami Kurosaki, Maria Clara Zanellati, Daniela Rita Pletto, Adele Finardi, Francesca Colciaghi, Enrico Garattini, Giorgio Stefano Battaglia

Research output: Contribution to journalArticle

Abstract

The key pathogenic steps leading to spinal muscular atrophy (SMA), a genetic disease characterized by selective motor neuron degeneration, are not fully clarified. The full-length SMN protein (FL-SMN), the main protein product of the disease gene SMN1, plays an established role in the cytoplasm in snRNP biogenesis ultimately leading to mRNA splicing within the nucleus. It is also involved in the mRNA axonal transport. However, to what extent the impairment of these two SMN functions contributes to SMA pathogenesis remains unknown. A shorter SMN isoform, axonal-SMN or a-SMN, with more specific axonal localization, has been discovered, but whether it might act in concert with FL-SMN in SMA pathogenesis is not known. As a first step in defining common or divergent intracellular roles of FL-SMN vs a-SMN proteins, we here characterized the turn-over of both proteins and investigated which pathway contributed to a-SMN degradation. We performed real time western blot and confocal immunofluorescence analysis in easily controllable in vitro settings. We analyzed co-transfected NSC34 and HeLa cells and cell clones stably expressing both a-SMN and FL-SMN proteins after specific blocking of transcript or protein synthesis and inhibition of known intracellular degradation pathways. Our data indicated that whereas the stability of both FL-SMN and a-SMN transcripts was comparable, the a-SMN protein was characterized by a much shorter half-life than FL-SMN. In addition, as already demonstrated for FL-SMN, the Ub/proteasome pathway played a major role in the a-SMN protein degradation. We hypothesize that the faster degradation rate of a-SMN vs FL-SMN is related to the protection provided by the protein complex in which FL-SMN is assembled. The diverse a-SMN vs FL-SMN C-terminus may dictate different protein interactions and complex formation explaining the different localization and role in the neuronal compartment, and the lower expression and stability of a-SMN.

Original languageEnglish
Article numbere0134163
JournalPLoS One
Volume10
Issue number7
DOIs
Publication statusPublished - Jul 27 2015

Fingerprint

protein isoforms
proteasome endopeptidase complex
Proteasome Endopeptidase Complex
Protein Isoforms
Degradation
degradation
Proteins
proteins
muscular atrophy
Spinal Muscular Atrophy
Survival of Motor Neuron 1 Protein
pathogenesis
Clone cells
Small Nuclear Ribonucleoproteins
Nerve Degeneration
Messenger RNA
Inborn Genetic Diseases
Axonal Transport
protein products
genetic disorders

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Locatelli, D., Terao, M., Kurosaki, M., Zanellati, M. C., Pletto, D. R., Finardi, A., ... Battaglia, G. S. (2015). Different stability and proteasome-mediated degradation rate of SMN protein isoforms. PLoS One, 10(7), [e0134163]. https://doi.org/10.1371/journal.pone.0134163

Different stability and proteasome-mediated degradation rate of SMN protein isoforms. / Locatelli, Denise; Terao, Mineko; Kurosaki, Mami; Zanellati, Maria Clara; Pletto, Daniela Rita; Finardi, Adele; Colciaghi, Francesca; Garattini, Enrico; Battaglia, Giorgio Stefano.

In: PLoS One, Vol. 10, No. 7, e0134163, 27.07.2015.

Research output: Contribution to journalArticle

Locatelli, D, Terao, M, Kurosaki, M, Zanellati, MC, Pletto, DR, Finardi, A, Colciaghi, F, Garattini, E & Battaglia, GS 2015, 'Different stability and proteasome-mediated degradation rate of SMN protein isoforms', PLoS One, vol. 10, no. 7, e0134163. https://doi.org/10.1371/journal.pone.0134163
Locatelli D, Terao M, Kurosaki M, Zanellati MC, Pletto DR, Finardi A et al. Different stability and proteasome-mediated degradation rate of SMN protein isoforms. PLoS One. 2015 Jul 27;10(7). e0134163. https://doi.org/10.1371/journal.pone.0134163
Locatelli, Denise ; Terao, Mineko ; Kurosaki, Mami ; Zanellati, Maria Clara ; Pletto, Daniela Rita ; Finardi, Adele ; Colciaghi, Francesca ; Garattini, Enrico ; Battaglia, Giorgio Stefano. / Different stability and proteasome-mediated degradation rate of SMN protein isoforms. In: PLoS One. 2015 ; Vol. 10, No. 7.
@article{ef400762894544e5943f96b2d9553a5d,
title = "Different stability and proteasome-mediated degradation rate of SMN protein isoforms",
abstract = "The key pathogenic steps leading to spinal muscular atrophy (SMA), a genetic disease characterized by selective motor neuron degeneration, are not fully clarified. The full-length SMN protein (FL-SMN), the main protein product of the disease gene SMN1, plays an established role in the cytoplasm in snRNP biogenesis ultimately leading to mRNA splicing within the nucleus. It is also involved in the mRNA axonal transport. However, to what extent the impairment of these two SMN functions contributes to SMA pathogenesis remains unknown. A shorter SMN isoform, axonal-SMN or a-SMN, with more specific axonal localization, has been discovered, but whether it might act in concert with FL-SMN in SMA pathogenesis is not known. As a first step in defining common or divergent intracellular roles of FL-SMN vs a-SMN proteins, we here characterized the turn-over of both proteins and investigated which pathway contributed to a-SMN degradation. We performed real time western blot and confocal immunofluorescence analysis in easily controllable in vitro settings. We analyzed co-transfected NSC34 and HeLa cells and cell clones stably expressing both a-SMN and FL-SMN proteins after specific blocking of transcript or protein synthesis and inhibition of known intracellular degradation pathways. Our data indicated that whereas the stability of both FL-SMN and a-SMN transcripts was comparable, the a-SMN protein was characterized by a much shorter half-life than FL-SMN. In addition, as already demonstrated for FL-SMN, the Ub/proteasome pathway played a major role in the a-SMN protein degradation. We hypothesize that the faster degradation rate of a-SMN vs FL-SMN is related to the protection provided by the protein complex in which FL-SMN is assembled. The diverse a-SMN vs FL-SMN C-terminus may dictate different protein interactions and complex formation explaining the different localization and role in the neuronal compartment, and the lower expression and stability of a-SMN.",
author = "Denise Locatelli and Mineko Terao and Mami Kurosaki and Zanellati, {Maria Clara} and Pletto, {Daniela Rita} and Adele Finardi and Francesca Colciaghi and Enrico Garattini and Battaglia, {Giorgio Stefano}",
year = "2015",
month = "7",
day = "27",
doi = "10.1371/journal.pone.0134163",
language = "English",
volume = "10",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "7",

}

TY - JOUR

T1 - Different stability and proteasome-mediated degradation rate of SMN protein isoforms

AU - Locatelli, Denise

AU - Terao, Mineko

AU - Kurosaki, Mami

AU - Zanellati, Maria Clara

AU - Pletto, Daniela Rita

AU - Finardi, Adele

AU - Colciaghi, Francesca

AU - Garattini, Enrico

AU - Battaglia, Giorgio Stefano

PY - 2015/7/27

Y1 - 2015/7/27

N2 - The key pathogenic steps leading to spinal muscular atrophy (SMA), a genetic disease characterized by selective motor neuron degeneration, are not fully clarified. The full-length SMN protein (FL-SMN), the main protein product of the disease gene SMN1, plays an established role in the cytoplasm in snRNP biogenesis ultimately leading to mRNA splicing within the nucleus. It is also involved in the mRNA axonal transport. However, to what extent the impairment of these two SMN functions contributes to SMA pathogenesis remains unknown. A shorter SMN isoform, axonal-SMN or a-SMN, with more specific axonal localization, has been discovered, but whether it might act in concert with FL-SMN in SMA pathogenesis is not known. As a first step in defining common or divergent intracellular roles of FL-SMN vs a-SMN proteins, we here characterized the turn-over of both proteins and investigated which pathway contributed to a-SMN degradation. We performed real time western blot and confocal immunofluorescence analysis in easily controllable in vitro settings. We analyzed co-transfected NSC34 and HeLa cells and cell clones stably expressing both a-SMN and FL-SMN proteins after specific blocking of transcript or protein synthesis and inhibition of known intracellular degradation pathways. Our data indicated that whereas the stability of both FL-SMN and a-SMN transcripts was comparable, the a-SMN protein was characterized by a much shorter half-life than FL-SMN. In addition, as already demonstrated for FL-SMN, the Ub/proteasome pathway played a major role in the a-SMN protein degradation. We hypothesize that the faster degradation rate of a-SMN vs FL-SMN is related to the protection provided by the protein complex in which FL-SMN is assembled. The diverse a-SMN vs FL-SMN C-terminus may dictate different protein interactions and complex formation explaining the different localization and role in the neuronal compartment, and the lower expression and stability of a-SMN.

AB - The key pathogenic steps leading to spinal muscular atrophy (SMA), a genetic disease characterized by selective motor neuron degeneration, are not fully clarified. The full-length SMN protein (FL-SMN), the main protein product of the disease gene SMN1, plays an established role in the cytoplasm in snRNP biogenesis ultimately leading to mRNA splicing within the nucleus. It is also involved in the mRNA axonal transport. However, to what extent the impairment of these two SMN functions contributes to SMA pathogenesis remains unknown. A shorter SMN isoform, axonal-SMN or a-SMN, with more specific axonal localization, has been discovered, but whether it might act in concert with FL-SMN in SMA pathogenesis is not known. As a first step in defining common or divergent intracellular roles of FL-SMN vs a-SMN proteins, we here characterized the turn-over of both proteins and investigated which pathway contributed to a-SMN degradation. We performed real time western blot and confocal immunofluorescence analysis in easily controllable in vitro settings. We analyzed co-transfected NSC34 and HeLa cells and cell clones stably expressing both a-SMN and FL-SMN proteins after specific blocking of transcript or protein synthesis and inhibition of known intracellular degradation pathways. Our data indicated that whereas the stability of both FL-SMN and a-SMN transcripts was comparable, the a-SMN protein was characterized by a much shorter half-life than FL-SMN. In addition, as already demonstrated for FL-SMN, the Ub/proteasome pathway played a major role in the a-SMN protein degradation. We hypothesize that the faster degradation rate of a-SMN vs FL-SMN is related to the protection provided by the protein complex in which FL-SMN is assembled. The diverse a-SMN vs FL-SMN C-terminus may dictate different protein interactions and complex formation explaining the different localization and role in the neuronal compartment, and the lower expression and stability of a-SMN.

UR - http://www.scopus.com/inward/record.url?scp=84941929719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941929719&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0134163

DO - 10.1371/journal.pone.0134163

M3 - Article

AN - SCOPUS:84941929719

VL - 10

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 7

M1 - e0134163

ER -